Volume 19 Number 10
31 October 2017

Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 10, 31 October

Ralff MD, Lulla AR, Wagner J, El-Deiry WS.
ONC201: a new treatment option being tested clinically for recurrent glioblastoma.
Transl Cancer Res. 2017 Oct 1, 2017;6(Suppl 7):S1239-S1243
. doi: 10.21037/tcr.2017.10.03. PMID: 30175049. Comment. ˍ
Refers to: Arrillaga-Romany I, et al., A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma.
Oncotarget. 2017 May 12, 2017;8(45):79298-79304. doi: 10.18632/oncotarget.17837. PMID: 29108308.
Interventional study. ˍ

Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP.
Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas.
Clin Nucl Med. 2017 Oct 1, 2017;42(10):e433-e435→. doi: 10.1097/RLU.0000000000001769.
PMID: 28737579. Case report. ˍ

Schettino C, Caranci F, Lus G, Signoriello E, Eoli M, Anghileri E, Pollo B, Melone MAB, Di Iorio G, Finocchiaro G, Ugga L, Tedeschi E.
Diffuse glioblastoma resembling acute hemorrhagic leukoencephalitis.
Quant Imaging Med Surg. 2017 Oct 1, 2017;7(5):592-597. doi: 10.21037/qims.2017.06.09.
PMID: 29184769. Case report. ˍ

Arvold ND, Shi DD, Aizer AA, Norden AD, Reardon DA, Lee EQ, Nayak L, Dunn IF, Golby AJ, Johnson MD, Claus EB, Chiocca EA, Ligon KL, Wen PY, Alexander BM.
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
J Neurooncol. 2017 Oct 3,
2017;135(3):581-591. doi: 10.1007/s11060-017-2611-9. PMID: 28975467. Observational study. ˍ

Cloughesy TF, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Ping J, Holland J, Weitzman R, Wen PY.
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients with prior antiangiogenic therapy.
Neuro Oncol. 2017 Oct 3,
2018;20(2):259-267. doi: 10.1093/neuonc/nox151. PMID: 29036345. Interventional study. ˍ

Tseng WL, Hsu HH, Chen Y, Tseng SH.
Tumor Recurrence in a Glioblastoma Patient after Discontinuation of Prolonged Temozolomide Treatment.
Asian J Neurosurg. 2017 Oct 3, 2017;12(4):727-730. doi: 10.4103/ajns.AJNS_39_15?
PMID: 29114295. Case report. ˍ

Liu Y, Yuelling LW, Wang Y, Du F, Gordon RE, O'Brien J, Ng JMY, Robins S, Lee EH, Liu H, Curran T, Yang ZJ.
Astrocytes promote medulloblastoma progression through hedgehog secretion.
Cancer Res. 2017 Oct 6,
2017;77(23):6692-6703. doi: 10.1158/0008-5472.CAN-17-1463. PMID: 28986380. Laboratory investigation. ˍ

Chang YL, Huang LC, Chen YC, Wang YW, Hueng DY, Huang SM.
The synergistic effects of valproic acid and fluvastatin on apoptosis induction in glioblastoma multiforme cell lines.
Int J Biochem Cell Biol. 2017 Oct 7,
2017;92:155-163. doi: 10.1016/j.biocel.2017.10.003. PMID: 29017950. Laboratory investigation. ˍ

Duerinck J, Du Four S, Bouttens F, Andre C, Verschaeve V, Van Fraeyenhove F, Chaskis C, D'Haene N, Le Mercier M, Rogiers A, Michotte A, Salmon I, Neyns B.
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
J Neurooncol. 2017 Oct 7,
2018;136(1):115-125. doi: 10.1007/s11060-017-2629-z. PMID: 28988341. Interventional study. ˍ

Majewska P, Ioannidis S, Raza MH, Tanna N, Bulbeck H, Williams M.
Postprogression survival in patients with glioblastoma treated with concurrent chemoradiotherapy: a routine care cohort study.
CNS Oncol. 2017 Oct 9,
2017;6(4):307-313. doi: 10.2217/cns-2017-0001. PMID: 28990795. Observational study. ˍ

De B, Beal K, De Braganca KC, Souweidane MM, Dunkel IJ, Khakoo Y, Gilheeney SW, DeAngelis LM, Menzel P, Patel SH, Wolden SL.
Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.
J Neurooncol. 2017 Oct 10, 2018;136(1):95-104
. doi: 10.1007/s11060-017-2627-1. PMID: 29019042. Observational study. ˍ

Ruiz VY, Praska CE, Armstrong G, Kollmeyer TM, Yamada S, Decker PA, Kosel ML, Eckel-Passow JE, Consortium TG, Lachance DH, Bainbridge MN, Melin BS, Bondy ML, Jenkins RB.
Molecular Subtyping of Tumors from Patients with Familial Glioma.
Neuro Oncol. 2017 Oct 10, 2018;20(6):810-817
. doi: 10.1093/neuonc/nox192. PMID: 29040662. Observational study. ˍ

Seidel C, von Bueren AO, Bojko S, Hoffmann M, Pietsch T, Gielen GH, Warmuth-Metz M, Bison B, Kortmann RD, Kramm CM.
Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen : Acute toxicity in pediatric high-grade glioma patients.
Strahlenther Onkol. 2017 Oct 11,
2018;194(3):215-224. doi: 10.1007/s00066-017-1218-6. PMID: 29022050. Observational study. ˍ

Boonyawan K, Hess KR, Yang J, Long L, Wang Q, Ezhilarasan R, Auia A, Alfaro-Munoz KD, de Groot JF, Bhat KP, Sulman EP.
A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma.
Oncotarget. 2017 Oct 12, 2017;8(52):90488-90495
. doi: 10.18632/oncotarget.21799. PMID: 29163847. Observational study. ˍ

Tini P, Nardone V, Pastina P, Battaglia G, Miracco C, Sebaste L, Rubino G, Cerase A, Pirtoli L.
Patients Affected by Unmethylated O(6)-Methylguanine-DNA Methyltransferase Glioblastoma Undergoing Radiochemotherapy May Benefit from Moderately Dose-Escalated Radiotherapy.
Biomed Res Int. 2017 Oct 12, 2017;2017:9461402
. doi: 10.1155/2017/9461402. PMID: 29159183. Observational study. ˍ

Johnson DR, Omuro AMP, Ravelo A, Sommer N, Guerin A, Ionescu-Ittu R, Shi S, Macalalad A, Uhm JH.
Overall survival in patients with glioblastoma before and after bevacizumab approval.
Curr Med Res Opin. 2017 Oct 13,
2018;34(5):813-820. doi: 10.1080/03007995.2017.1392294. PMID: 29025274. Observational study. ˍ

Moriya S, Ohba S, Adachi K, Nishiyama Y, Hayashi T, Nagahisa S, Kaito T, Nakae S, Hirose Y.
A retrospective study of bevacizumab for treatment of brainstem glioma with malignant features.
J Clin Neurosci. 2017 Oct 16,
2018;47:228-233. doi: 10.1016/j.jocn.2017.10.002. PMID: 29050897. Observational study. ˍ

Møller S, Munck Af Rosenschöld P, Costa J, Law I, Poulsen HS, Engelholm SA, Engelholm S.
Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.
Radiother Oncol. 2017 Oct 17,
2017;125(2):223-227. doi: 10.1016/j.radonc.2017.09.039. PMID: 29054380. Interventional study. ˍ

Mokhtech M, Morris CG, Indelicato DJ, Rutenberg MS, Amdur RJ.
Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.
Am J Clin Oncol. 2017 Oct 17, 2018;41(10):1015-1018
. doi: 10.1097/COC.0000000000000407. PMID: 29045264. Observational study. ˍ

Semyachkina-Glushkovskaya O, Kurths J, Borisova E, Sokolovski S, Mantareva V, Angelov I, Shirokov A, Navolokin N, Shushunova N, Khorovodov A, Ulanova M, Sagatova M, Agranivich I, Sindeeva O, Gekalyuk A, Bodrova A, Rafailov E.
Photodynamic opening of blood-brain barrier.
Biomed Opt Express. 2017 Oct 17, 2017;8(11):5040-5048
. doi: 10.1364/BOE.8.005040. PMID: 29188101. Laboratory investigation. ˍ

Yeboa DN, Rutter CE, Park HS, Lester-Coll NH, Corso CD, Mancini BR, Bindra RS, Contessa J, Yu JB.
Patterns of care and outcomes for use of concurrent chemoradiotherapy over radiotherapy alone for anaplastic gliomas.
Radiother Oncol. 2017 Oct 17, 2017;125(2):258-265
. doi: 10.1016/j.radonc.2017.09.027. PMID: 29054377. Observational study. ˍ

Tini P, Nardone V, Pastina P, Battaglia G, Miracco C, Carbone SF, Sebaste L, Rubino G, Cerase A, Pirtoli L.
Epidermal Growth Factor Receptor Expression predicts Time and Patterns of Recurrence in Glioblastoma Patients Following Radiotherapy and Temozolomide.
World Neurosurg. 2017 Oct 20,
2018;109:e662-e668. doi: 10.1016/j.wneu.2017.10.052. PMID: 29061455. Observational study. ˍ

Ozdemir ES, Yildirim AE, Can AY.
Primary Central Nervous System Lymphoma of Optic Chiasma: Endoscopic Endonasal Treatment.
J Craniofac Surg. 2017 Oct 23,
2018;29(1):199-201. doi: 10.1097/SCS.0000000000004059. PMID: 29065048. Case report. ˍ

van Zanten SEMV, El-Khouly FE, Jansen MHA, Bakker DP, Aliaga ES, Haasbeek CJA, Wolf NI, Zwaan CM, Vandertop WP, van Vuurden DG, Kaspers GJL.
Correction to: A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Oct 23, 2018;136(1):219-220
. doi: 10.1007/s11060-017-2636-0. PMID: 29063425. Correction. ˍ
Refers to: Veldhuijzen van Zanten SEM, et al., A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma.
J Neurooncol. 2017 Jul 26, 2017;135(2):307-315. doi: 10.1007/s11060-017-2575-9. PMID: 28748343. Interventional study. ˍ

Lam S, Lin Y, Zinn P, Su J, Pan IW.
Patient and treatment factors associated with survival among pediatric glioblastoma patients: A Surveillance, Epidemiology, and End Results study.
J Clin Neurosci. 2017 Oct 25,
2018;47:285-293. doi: 10.1016/j.jocn.2017.10.041. PMID: 29102237. Observational study. ˍ


Yuan Y, Ross J, Shi Q, Davis FG.
Conditional survival after a diagnosis of malignant brain tumour in Canada: 2000-2008.
Curr Oncol. 2017 Oct 25, 2017;24(5):e341-e347
. doi: 10.3747/co.24.3579. PMID: 29089803. Observational study. ˍ


Gately L, McLachlan SA, Philip J, Ruben J, Dowling A.
Long-term survivors of glioblastoma: a closer look.
J Neurooncol. 2017 Oct 27, 2018;136(1):155-162
. doi: 10.1007/s11060-017-2635-1. PMID: 29079955. Observational study. ˍ

Tejada S, Alonso M, Patiño A, Fueyo J, Gomez-Manzano C, Diez-Valle R.
Phase I Trial of DNX-2401 for Diffuse Intrinsic Pontine Glioma Newly Diagnosed in Pediatric Patients.
Neurosurgery. 2017 Oct 27,
2018;83(5):1050-1056. doi: 10.1093/neuros/nyx507. PMID: 29088386. Interventional study. ˍ


Díez Valle R, Becerra Castro V, Marigil Sánchez M, Gállego Pérez-Larraya J, Núñez-Córdoba JM, Tejada Solis S.
Results of a Policy of Fast Tapering of Steroids After Resection Surgery in Glioblastoma.
World Neurosurg. 2017 Oct 28,
2018;109:e845-e852. doi: 10.1016/j.wneu.2017.10.110. PMID: 29107723. Observational study. ˍ

Osborn VW, Lee A, Garay E, Safdieh J, Schreiber D.
Impact of Timing of Adjuvant Chemoradiation for Glioblastoma in a Large Hospital Database.
Neurosurgery. 2017 Oct 28,
2018;83(5):915-921. doi: 10.1093/neuros/nyx497. PMID: 29092047. Observational study. ˍ

Bae JW, Hong EK, Gwak HS.
Response of Leptomeningeal Dissemination of Anaplastic Glioma to Temozolomide: Experience of Two Cases.
Brain Tumor Res Treat. 2017 Oct 31, 2017;5(2):99-104
. doi: 10.14791/btrt.2017.5.2.99. PMID: 29188211. Case report. ˍ

Ryu HS, Moon KS, Lee KH, Jang WY, Jung TY, Kim IY, Jung S.
Recurred Intracranial Meningioma: A Retrospective Analysis for Treatment Outcome and Prognostic Factor.
Brain Tumor Res Treat. 2017 Oct 31, 2017;5(2):54-63
. doi: 10.14791/btrt.2017.5.2.54. PMID: 29188205. Observational study. ˍ